Immunovant shifts primary focus to IMVT-1402, a next-generation anti-FcRn, targeting Graves' Disease with potential ...
Phase 3 study builds on positive phase 2 results showing rapid and sustained reductions in key disease biomarkers and ...
Immunovant ( ($IMVT) ) has issued an announcement. On December 10, 2025, Immunovant announced the pricing of an underwritten offering of its ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...
Williams] does not have frontotemporal dementia, so that should be game, set, match,” famed attorney Joe Tacopina said in an ...
Watts challenged the decision in the Personal Injury Commission and represented himself during the proceedings. EML’s case ...
New Chronic Wasting Disease surveillance measures are now in effect for Casey, Laurel, Lincoln, McCreary, Pulaski, Rockcastle ...
Eun Lee, MD Thyroid blood tests are an important part of diagnosing and treating thyroid disease. Based on how high or low ...